Hancock Jaffe Successfully Starts First-in-Human VenoValve Study
19 févr. 2019 08h31 HE
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today...
Hancock Jaffe Announces Objectives for Upcoming CoreoGraft Study
28 janv. 2019 08h00 HE
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today...
Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference
15 janv. 2019 08h00 HE
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today...
Hancock Jaffe Announces End Points for First-in-Human VenoValve Study
09 janv. 2019 08h00 HE
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today...
Hancock Jaffe Receives Approval for First-in-Human VenoValve Study
17 déc. 2018 08h00 HE
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health,...
Hancock Jaffe Announces January CoreoGraft Study at the Texas Heart Institute
04 déc. 2018 08h00 HE
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health,...
Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia
20 nov. 2018 08h00 HE
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health,...
Hancock Jaffe Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality Assurance
13 nov. 2018 09h30 HE
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, today...
Hancock Jaffe Enters into Sponsored Research Agreement for CoreoGraft with World-Renowned Texas Heart Institute
09 oct. 2018 06h00 HE
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health,...
Hancock Jaffe Appoints Three New Independent Directors
02 oct. 2018 06h00 HE
|
Hancock Jaffe Laboratories, Inc.
Accomplished medical device professionals and nationally recognized fund manager and analystbring key experience to the leadership of cardiac and vascular device company IRVINE, Calif., Oct. 02,...